In the pharmaceutical industry, packaging and labelling are far more than branding or presentation tools—they are essential components of regulatory compliance and patient safety. Printed packaging and labelling communicate critical information such as dosage instructions, warnings, storage requirements, and batch details.
Even the smallest error in artwork or labelling can have severe consequences, ranging from regulatory findings and costly product recalls to risks to patient health. This is why audits of printed packaging and labelling suppliers are a crucial element of pharmaceutical quality management systems.
Why Packaging and Labelling Audits Matter
- Regulatory Compliance
Agencies such as the MHRA, EMA, and FDA enforce strict requirements for pharmaceutical packaging and labelling. Audits help confirm that suppliers comply with Good Manufacturing Practice (GMP), ensuring printed materials are accurate, consistent, and traceable. - Patient Safety
Incorrect or missing information on a medicine pack can lead to patient harm. Auditing packaging and labelling processes ensures accuracy in dosage instructions, warnings, and product identification, minimising the risk of medication errors. - Supply Chain Integrity
Packaging and labelling play a key role in product authenticity and protection against counterfeiting. Audits verify whether security features, barcodes, and serialisation measures are properly applied. - Risk Mitigation
Common risks in packaging and labelling include version control errors, print defects, or unauthorised changes to artwork. Regular audits identify these risks early and drive corrective actions before products reach the market.
Common Audit Focus Areas for Packaging and Labelling
When auditing printed packaging and labelling suppliers, pharmaceutical companies typically review:
- Artwork Management Systems – processes for version control, approval workflows, and change management.
- Print Quality and Accuracy – checks on legibility, font size, colours, and alignment.
- Regulatory Information – ensuring compliance with local and international labelling requirements.
- Traceability – controls for batch coding, serialisation, and reconciliation of printed components.
- Supplier Quality Systems – training, SOPs, CAPA (Corrective and Preventive Actions), and documentation practices.
- Data Integrity – assurance that electronic artwork files are secure, validated, and protected from unauthorised modification.
How Audits Prevent Regulatory Pitfalls
- Error Detection Before Release – audits ensure discrepancies in printed materials are identified before distribution.
- Evidence of Due Diligence – documented audits demonstrate to regulators that the company has verified supplier compliance.
- Improved Supplier Performance – audits promote continuous improvement by highlighting gaps and best practices.
- Reduced Recall Risk – proactive audits help avoid costly and reputation-damaging recalls due to packaging or labelling errors.
Q&V’s Expertise in Packaging & Labelling Audits
At Q&V, we understand the high stakes of pharmaceutical packaging and labelling. Our expert auditors conduct in-depth supplier audits of printed packaging and labelling providers, ensuring full alignment with GMP, GDP, and global regulatory requirements.
Our services include:
- Comprehensive audits of packaging and labelling suppliers.
- Risk-based evaluations of artwork management and version control processes.
- Detailed audit reports with practical, regulator-ready recommendations.
- Ongoing supplier monitoring to ensure continuous compliance.
By working with Q&V, pharmaceutical companies can safeguard accuracy, regulatory compliance, and patient safety throughout their supply chain.